Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
PMD-026 by Phoenix Molecular Designs for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
PMD-026 is under clinical development by Phoenix Molecular Designs and currently in Phase II for Human Epidermal Growth Factor Receptor...
Data Insights
PMD-026 by Phoenix Molecular Designs for Metastatic Breast Cancer: Likelihood of Approval
PMD-026 is under clinical development by Phoenix Molecular Designs and currently in Phase II for Metastatic Breast Cancer. According to...